CASI Pharmaceuticals Inc Strategic Asset Allocation Index
CASI Pharmaceuticals Inc strategic asset allocation index. CASI Pharmaceuticals Inc (CASI) has a Strategic Asset Allocation Index of 92.7% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $1.72 Million) total $1.72 Million, measured against net assets of $1.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CASI Pharmaceuticals Inc (CASI) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CASI Pharmaceuticals Inc (2000–2024)
Strategic asset allocation index of CASI Pharmaceuticals Inc from 2000 to 2024. This chart shows how CASI Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2024. As of December 2024, the index stands at 92.7%, representing strategic assets of $1.72 Million against net assets of $1.85 Million USD. Check CASI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
CASI Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2024)
CASI Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for CASI Pharmaceuticals Inc from 2000 to 2024, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CASI market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 92.7% | $1.72 Million | $- | $1.72 Million | $1.85 Million | ▲ +85.8 pp |
| 2023 | 7.0% | $1.68 Million | $- | $1.68 Million | $24.16 Million | ▼ -4.2 pp |
| 2022 | 11.2% | $7.46 Million | $- | $7.46 Million | $66.93 Million | ▼ -46.4 pp |
| 2021 | 57.5% | $62.12 Million | $22.00 Million | $40.13 Million | $107.96 Million | ▲ +18.7 pp |
| 2020 | 38.8% | $40.20 Million | $10.76 Million | $29.44 Million | $103.57 Million | ▲ +22.8 pp |
| 2019 | 16.0% | $15.02 Million | $985.00K | $14.04 Million | $93.67 Million | ▲ +14.4 pp |
| 2018 | 1.6% | $1.75 Million | $1.75 Million | $- | $109.46 Million | ▼ -1.1 pp |
| 2017 | 2.7% | $1.05 Million | $1.05 Million | $- | $38.54 Million | ▲ +1.6 pp |
| 2016 | 1.1% | $229.59K | $229.59K | $- | $20.78 Million | ▲ +0.6 pp |
| 2013 | 0.5% | $78.14K | $78.14K | $- | $14.94 Million | ▼ -0.1 pp |
| 2012 | 0.6% | $53.00K | $53.00K | $- | $8.24 Million | ▼ -0.3 pp |
| 2011 | 1.0% | $25.00K | $25.00K | $- | $2.53 Million | ▼ -1.0 pp |
| 2010 | 1.9% | $104.00K | $104.00K | $- | $5.33 Million | ▼ -2.5 pp |
| 2008 | 4.5% | $264.00K | $264.00K | $- | $5.92 Million | ▲ +2.1 pp |
| 2007 | 2.3% | $621.00K | $621.00K | $- | $26.90 Million | ▲ +0.5 pp |
| 2006 | 1.8% | $848.00K | $848.00K | $- | $46.98 Million | ▼ -1.3 pp |
| 2005 | 3.1% | $915.00K | $915.00K | $- | $29.39 Million | ▼ -0.1 pp |
| 2004 | 3.2% | $1.15 Million | $1.15 Million | $- | $35.72 Million | ▼ -2.5 pp |
| 2003 | 5.7% | $1.99 Million | $1.99 Million | $- | $34.88 Million | ▼ -24.3 pp |
| 2002 | 30.0% | $3.15 Million | $3.15 Million | $- | $10.51 Million | ▲ +12.0 pp |
| 2001 | 18.0% | $4.18 Million | $4.18 Million | $- | $23.21 Million | ▼ -6.0 pp |
| 2000 | 24.0% | $4.58 Million | $4.58 Million | $- | $19.06 Million | — |